Utilizing cell line-derived organoids to evaluate the efficacy of a novel LIFR-inhibitor, EC359 in targeting pancreatic tumor stroma
- Bradley R. Hall
- , Andrew Cannon
- , Christopher Thompson
- , Bindu Santhamma
- , Alejandra Chavez-Riveros
- , Rakesh Bhatia
- , Hareesh B. Nair
- , Klaus Nickisch
- , Surinder K. Batra
- , Sushil Kumar
Research output: Contribution to journal › Article › peer-review
24
Link opens in a new tab
Scopus
citations